UROMED HIRING DIRECT SALES FORCE FOR RELIANCE U.S. LAUNCH IN LATE 1996; FEMALE URINARY INCONTINENCE INSERT TO BE PRICED COMPETITIVELY WITH DIAPER USE
This article was originally published in The Gray Sheet
UroMed has begun building a direct U.S. sales force to launch its Reliance insert for female urinary stress incontinence, the company says. The firm gained approval of the device on Aug. 21, and expects to roll it out nationwide late this year.
You may also be interested in...
AMAG outlines plans for retrospective real-world evidence studies, and possibly a new placebo-controlled trial with a primary endpoint of preterm birth <32 weeks, in a filing opposing the Center for Drug Evaluation and Research’s proposal to withdraw the drug.
The leading Korean pharma firm’s oral, third-generation EGFR-TKI is approved in the country, providing a new option for patients with advanced NSCLC and increasing hopes for global approvals given an ongoing global Phase III combination trial led by partner J&J.
DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.